About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [512 citations: 1–100 of 459 articles]

Articles published in Schizophrenia Research and Treatment have been cited 512 times. The following is a list of the 459 articles that have cited the articles published in Schizophrenia Research and Treatment.

  • Joseph E. Pero, Michael A. Rossi, Michael J. Kelly, Hannah D. G. F. Lehman, Mark E. Layton, Robert M. Garbaccio, Julie A. O’Brien, Brian C. Magliaro, Jason M. Uslaner, Sarah L. Huszar, Kerry L. Fillgrove, Cuyue Tang, Yuhsin Kuo, Leo A. Joyce, Edward C. Sherer, and Marlene A. Jacobson, “Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDI,” ACS Medicinal Chemistry Letters, 2016. View at Publisher · View at Google Scholar
  • Amany I. Shehata, Faika I. Hassanein, and Rashad Abdul-Ghani, “Seroprevalence of Toxoplasma gondii infection among patients with non-schizophrenic neurodevelopmental disorders in Alexandria, Egypt,” Acta Tropica, vol. 154, pp. 155–159, 2016. View at Publisher · View at Google Scholar
  • Martin Krause, Martin Brüne, and Carsten Theiss, “Preparation of human formalin-fixed brain slices for electron microscopic investigations,” Annals of Anatomy - Anatomischer Anzeiger, 2016. View at Publisher · View at Google Scholar
  • Tak Lam Lo, Matthew Warden, Yanling He, Tianmei Si, Seshadri Kalyanasundaram, Manickam Thirunavukarasu, Nurmiati Amir, Ahmad Hatim, Tomas Bautista, Cheng Lee, Robin Emsley, Jose Olivares, Yen Kuang Yang, Ronnachai Kongsakon, and David Castle, “Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region,” Asia-Pacific Psychiatry, vol. 8, no. 2, pp. 154–171, 2016. View at Publisher · View at Google Scholar
  • Xiaomei Ma, Di Wang, Yujing Zhou, Chuanjun Zhuo, Wen Qin, Jiajia Zhu, and Chunshui Yu, “Sex-dependent alterations in resting-state cerebral blood flow, amplitude of low-frequency fluctuations and their coupling relationship in schizophren,” Australian And New Zealand Journal Of Psychiatry, vol. 50, no. 4, pp. 334–344, 2016. View at Publisher · View at Google Scholar
  • Guusje Collin, Elise Turk, and Martijn P. van den Heuvel, “Connectomics in schizophrenia: from early pioneers to recent brain network findings,” Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2016. View at Publisher · View at Google Scholar
  • Li Shao, Khashayar Golbaz, William G Honer, and Clare L Beasley, “Deficits in axon-associated proteins in prefrontal white matter in bipolar disorder but not schizophrenia,” Bipolar Disorders, 2016. View at Publisher · View at Google Scholar
  • Wenyi Qin, Cong Liu, Monsheel Sodhi, and Hui Lu, “Meta-analysis of sex differences in gene expression in schizophrenia,” Bmc Systems Biology, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Ana P. Pinheiro, Neguine Rezaii, Paul G. Nestor, Andréia Rauber, Kevin M. Spencer, and Margaret Niznikiewicz, “Did you or I say pretty, rude or brief? An ERP study of the effects of speaker’s identity on emotional word processing,” Brain and Language, vol. 153-154, pp. 38–49, 2016. View at Publisher · View at Google Scholar
  • L E Laskaris, M A Di Biase, I Everall, G Chana, A Christopoulos, E Skafidas, V L Cropley, and C Pantelis, “Microglial activation and progressive brain changes in schizophrenia,” British Journal of Pharmacology, vol. 173, no. 4, pp. 666–680, 2016. View at Publisher · View at Google Scholar
  • Kenneth Asogwa, Carolina Nisenoff, and Jerome Okudo, “Foreign Accent Syndrome, a Rare Presentation of Schizophrenia in a 34-Year-Old African American Female: A Case Report and Literature Review,” Case Reports in Psychiatry, vol. 2016, pp. 1–5, 2016. View at Publisher · View at Google Scholar
  • Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, Thomas M. Bridges, Karen J. Gregory, Colleen M. Niswender, and P. Jeffrey Conn, “Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors,” Chemical Reviews, 2016. View at Publisher · View at Google Scholar
  • Deanna L. Kelly, Laura M. Rowland, Kathleen M. Patchan, Kelli Sullivan, Amber Earl, Heather Raley, Fang Liu, Stephanie Feldman, and Robert P. McMahon, “Schizophrenia clinical symptom differences in women vs. men with and without a history of childhood physical abuse,” Child and Adolescent Psychiatry and Mental Health, vol. 10, no. 1, 2016. View at Publisher · View at Google Scholar
  • Yan-Yan Wei, Ji-Jun Wang, Chao Yan, Zi-Qiang Li, Xiao Pan, Yi Cui, Tong Su, Tao-Sheng Liu, and Yun-Xiang Tang, “Correlation Between Brain Activation Changes and Cognitive Improvement Following Cognitive Remediation Therapy in Schizophrenia: An Activation Likelihood Estimation Meta-analysis,” Chinese Medical Journal, vol. 129, no. 5, pp. 578, 2016. View at Publisher · View at Google Scholar
  • Javier Quintero, Itziar Oyagüez, Beatriz González, Ignacio Cuervo-Arango, Ignacio García, and Miguel Angel Casado, “Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain,” Clinical Drug Investigation, vol. 36, no. 6, pp. 479–490, 2016. View at Publisher · View at Google Scholar
  • Eduard Parellada, and Miquel Bioque, “Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia,” CNS Drugs, 2016. View at Publisher · View at Google Scholar
  • Bernard Crespi, Emma Leach, Natalie Dinsdale, Mikael Mokkonen, and Peter Hurd, “Imagination in human social cognition, autism, and psychotic-affective conditions,” Cognition, vol. 150, pp. 181–199, 2016. View at Publisher · View at Google Scholar
  • Julia E.H. Brown, Gisela Mezquida, and Emilio Fernandez-Egea, “Well-being in clozapine-treated schizophrenia patients: The significance of positive symptoms,” Comprehensive Psychiatry, vol. 68, pp. 140–146, 2016. View at Publisher · View at Google Scholar
  • Süheyla Doğan Bulut, Serdar Bulut, and Olga Güriz, “The Relationship Between Sex Hormone Profiles and Symptoms of Schizophrenia in men,” Comprehensive Psychiatry, 2016. View at Publisher · View at Google Scholar
  • Manuela Ferrari, Nina Flora, Kelly K. Anderson, Asante Haughton, Andrew Tuck, Suzanne Archie, Sean Kidd, and Kwame McKenzie, “Gender differences in pathways to care for early psychosis,” Early Intervention in Psychiatry, 2016. View at Publisher · View at Google Scholar
  • Patrick Raynal, Tiffany Melioli, and Henri Chabrol, “Personality profiles in young adults with disordered eating behavior,” Eating Behaviors, 2016. View at Publisher · View at Google Scholar
  • JishaM Lucca, Madhan Ramesh, Dushad Ram, Jintu Kurian, and Noyal Mathew, “Psychotropic medication-induced sexual dysfunction and its interference with patient′s daily performance: a cross-sectional study,” Egyptian Journal of Psychiatry, vol. 37, no. 1, pp. 36, 2016. View at Publisher · View at Google Scholar
  • B. Moreno-Kuestner, F. Mayoral, D. Navas-Campana, J. M. Garcia-Herrera, P. Angona, C. Martin, and F. Rivas, “Prevalence of schizophrenia and related disorders in Malaga (Spain): results using multiple clinical databases,” Epidemiology And Psychiatric Sciences, vol. 25, no. 1, pp. 38–48, 2016. View at Publisher · View at Google Scholar
  • R. Daglas, S. M. Cotton, K. Allott, M. Yuecel, C. A. Macneil, M. K. Hasty, B. Murphy, C. Pantelis, K. T. Hallam, L. P. Henry, P. Conus, A. Ratheesh, L. Kader, M. Th Wong, P. D. McGorry, and M. Berk, “A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first e,” European Psychiatry, vol. 31, no. 1, pp. 20–28, 2016. View at Publisher · View at Google Scholar
  • J.M. Moilanen, M. Haapea, E. Jääskeläinen, J.M. Veijola, M.K. Isohanni, H.J. Koponen, and J. Miettunen, “Long-term antipsychotic use and its association with outcomes in schizophrenia – the Northern Finland Birth Cohort 1966,” European Psychiatry, vol. 36, pp. 7–14, 2016. View at Publisher · View at Google Scholar
  • L Hargarter, P Bergmans, P Cherubin, S Keim, A Conca, A Serrano-Blanco, I Bitter, N Bilanakis, and A Schreiner, “Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia,” Expert Opinion on Pharmacotherapy, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Matt A. Brown, Ram J. Bishnoi, Sara Dholakia, and Dawn I. Velligan, “Methodological issues associated with preclinical drug development and increased placebo effects in schizophrenia clinical trials,” Expert Review of Clinical Pharmacology, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Eva A. Malt, Katalin Juhasz, Ulrik F. Malt, and Thomas Naumann, “A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies,” Frontiers in Behavioral Neuroscience, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Elizabeth B. Torres, Robert W. Isenhower, Jillian Nguyen, Caroline Whyatt, John I. Nurnberger, Jorge V. Jose, Steven M. Silverstein, Thomas V. Papathomas, Jacob Sage, and Jonathan Cole, “Toward Precision Psychiatry: Statistical Platform for the Personalized Characterization of Natural Behaviors,” Frontiers in Neurology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Marcella Bellani, Filippo Boschello, Giuseppe Delvecchio, Nicola Dusi, Carlo Alfredo Altamura, Mirella Ruggeri, and Paolo Brambilla, “DTI and Myelin Plasticity in Bipolar Disorder: Integrating Neuroimaging and Neuropathological Findings,” Frontiers in Psychiatry, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Elodie Peyroux, and Nicolas Franck, “Improving Social Cognition in People with Schizophrenia with RC2S: Two Single-Case Studies,” Frontiers in Psychiatry, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Antje Heinrich, Helen Henshaw, and Melanie A. Ferguson, “Only Behavioral But Not Self-Report Measures of Speech Perception Correlate with Cognitive Abilities,” Frontiers in Psychology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Susana Mingote, Justine Masson, Celia Gellman, Gretchen M. Thomsen, Chyuan-Sheng Lin, Robert J. Merker, Inna Gaisler-Salomon, Yvonne Wang, Rachel Ernst, René Hen, and Stephen Rayport, “Genetic Pharmacotherapy as an Early CNS Drug Development Strategy: Testing Glutaminase Inhibition for Schizophrenia Treatment in Adult Mice,” Frontiers in Systems Neuroscience, vol. 9, 2016. View at Publisher · View at Google Scholar
  • JudithMiti Ogorchukwu, VaralakshmiChandra Sekaran, Sreekumaran Nair, and Lena Ashok, “Mental health literacy among late adolescents in South India: What they know and what attitudes drive them,” Indian Journal of Psychological Medicine, vol. 38, no. 3, pp. 234, 2016. View at Publisher · View at Google Scholar
  • Meng-Juan Jing, Wei-Quan Lin, Qiang Wang, Jia-Ji Wang, Jie Tang, En-She Jiang, Yi-Xiong Lei, and Pei-Xi Wang, “Reliability and Construct Validity of Two Versions of Chalder Fatigue Scale among the General Population in Mainland China,” International Journal of Environmental Research and Public Health, vol. 13, no. 2, pp. 147, 2016. View at Publisher · View at Google Scholar
  • Md. Nur Kabidul Azam, Md. Mizanur Rahman, Samanta Biswas, and Md. Nasir Ahmed, “Appraisals of Bangladeshi Medicinal Plants Used by Folk Medicine Practitioners in the Prevention and Management of Malignant Neoplastic Diseases,” International Scholarly Research Notices, vol. 2016, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  • Brenda Happell, Robert Stanton, Danya Hodgetts, and David Scott, “Quality of Life Outcomes in Community-based Mental Health Consumers: Comparisons with Population Norms and Changes over Time,” Issues in Mental Health Nursing, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Henderikus G. O. M. Smid, Richard Bruggeman, and Sander Martens, “Normal Cognitive Conflict Resolution in Psychosis Patients With and Without Schizophrenia,” Journal Of Abnormal Psychology, vol. 125, no. 1, pp. 88–103, 2016. View at Publisher · View at Google Scholar
  • Abhijit Dey, Saheli Das, and Anuradha Mukherjee, “Possible natural therapeutics against schizophrenia and its acute and treatment resistant forms: a review,” Journal of Biologically Active Products from Nature, vol. 6, no. 1, pp. 1–24, 2016. View at Publisher · View at Google Scholar
  • Ugo Ikwuka, Niall Galbraith, Ken Manktelow, Josephine Chen-Wilson, Femi Oyebode, Rosemary C. Muomah, and Anuli Igboaka, “Ideological vs. Instrumental Barriers to Accessing Formal Mental Health care in the Developing World: Focus on South-eastern Nigeria,” Journal Of Health Care For The Poor And Underserved, vol. 27, no. 1, pp. 157–175, 2016. View at Publisher · View at Google Scholar
  • Wesley Williams, Christopher McKinney, Larry Martinez, and Carmela Benson, “Recovery outcomes of schizophrenia patients treated with paliperidone palmitate in a community setting: patient and provider perspectives on recovery,” Journal Of Medical Economics, vol. 19, no. 5, pp. 469–476, 2016. View at Publisher · View at Google Scholar
  • F. Shaddel, M. Ghazirad, D. O’Leary, and S. Banerjee, “How Psychotropic Drugs Are Used; an Explanatory Paradigm,” Journal of Medical Hypotheses and Ideas, 2016. View at Publisher · View at Google Scholar
  • Yuta Yoshino, Kentaro Kawabe, Kiyohiro Yamazaki, Shinya Watanabe, Shusuke Numata, Yoko Mori, Taku Yoshida, Junichi Iga, Tetsuro Ohmori, and Shu-ichi Ueno, “Elevated TREM2 mRNA expression in leukocytes in schizophrenia but not major depressive disorder,” Journal of Neural Transmission, vol. 123, no. 6, pp. 637–641, 2016. View at Publisher · View at Google Scholar
  • Laura Nisenbaum, AnnCatherine Downing, Fangyi Zhao, Brian Millen, Leanne Munsie, Bruce Kinon, David Adams, Juan Gomez, and Michelle Penny, “Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia,” Journal of Personalized Medicine, vol. 6, no. 1, pp. 9, 2016. View at Publisher · View at Google Scholar
  • P. C. van der Ende, J. T. van Busschbach, J. Nicholson, E. L. Korevaar, and J. van Weeghel, “Strategies for parenting by mothers and fathers with a mental illness,” Journal of Psychiatric and Mental Health Nursing, 2016. View at Publisher · View at Google Scholar
  • Shayden Bryce, Elise Sloan, Stuart Lee, Jennie Ponsford, and Susan Rossell, “Cognitive remediation in schizophrenia: A methodological appraisal of systematic reviews and meta-analyses,” Journal of Psychiatric Research, 2016. View at Publisher · View at Google Scholar
  • Joseph Walsh, “Schizotypal Personality Disorder: A Clinical Social Work Perspective,” Journal of Social Work Practice, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  • R-R Wu, F-Y Zhang, K-M Gao, J-J Ou, P Shao, H Jin, W-B Guo, P K Chan, and J-P Zhao, “Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials,” Molecular Psychiatry, 2016. View at Publisher · View at Google Scholar
  • Xingyun Liu, Chuanjun Zhuo, Wen Qin, Jiajia Zhu, Lixue Xu, Yongjie Xu, and Chunshui Yu, “Selective functional connectivity abnormality of the transition zone of the inferior parietal lobule in schizophrenia,” NeuroImage: Clinical, 2016. View at Publisher · View at Google Scholar
  • Cristiana Montemagni, Tiziana Frieri, and Paola Rocca, “Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life,” Neuropsychiatric Disease And Treatment, vol. 12, pp. 917–929, 2016. View at Publisher · View at Google Scholar
  • Andrea de Bartolomeis, Andrea Fagiolini, Marco Vaggi, and Claudio Vampini, “Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-a,” Neuropsychiatric Disease And Treatment, vol. 12, pp. 99–108, 2016. View at Publisher · View at Google Scholar
  • Jillian Nguyen, Ushma Majmudar, V. Papathomas Thomas, Steven M. Silverstein, and Elizabeth B. Torres, “Schizophrenia: The Micro-Movements Perspective,” Neuropsychologia, 2016. View at Publisher · View at Google Scholar
  • Antonio Vita, Giacomo Deste, Stefano Barlati, Roberto Poli, Paolo Cacciani, Luca De Peri, and Emilio Sacchetti, “Feasibility and effectiveness of cognitive remediation in the treatment of borderline personality disorder,” Neuropsychological Rehabilitation, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  • Younghwa Lee, Se Jin Jeon, Ji Woong Choi, and Jong Hoon Ryu, “Activation of maternal toll-like receptor-2 causes social deficits and memory impairment in female offspring,” Neuroreport, vol. 27, no. 4, pp. 224–229, 2016. View at Publisher · View at Google Scholar
  • H. Wu, X. Wang, Y. Gao, F. Lin, T. Song, Y. Zou, L. Xu, and H. Lei, “Nmda Receptor Antagonism By Repetitive Mk801 Administration Induces Schizophrenia-Like Structural Changes In The Rat Brain As Revealed By Voxel-Based ,” Neuroscience, vol. 322, pp. 221–233, 2016. View at Publisher · View at Google Scholar
  • Ali Mohammad Pourrahimi, Shahrzad Mazhari, Mohammad Shabani, Yousef Moghadas Tabrizi, and Vahid Sheibani, “Title: Numerical distance effect in patients with schizophrenia,” Neuroscience Letters, 2016. View at Publisher · View at Google Scholar
  • Beatrix Benz, Sandra Unholzer, Alexandra Köppl, and Ekkehard Haen, “Therapiealternative mit einem neuen Depotantipsychotikum,” NeuroTransmitter, vol. 27, no. 5, pp. 42–46, 2016. View at Publisher · View at Google Scholar
  • Ernst von Kardorff, Ali Soltaninejad, Mohammad Kamali, and Mahin Eslami Shahrbabaki, “Family caregiver burden in mental illnesses: The case of affective disorders and schizophrenia - a qualitative exploratory study,” Nordic Journal Of Psychiatry, vol. 70, no. 4, pp. 248–254, 2016. View at Publisher · View at Google Scholar
  • Richard Moulding, Simon Nix-Carnell, Alexandra Schnabel, Maja Nedeljkovic, Emma E. Burnside, Aaron F. Lentini, and Nazia Mehzabin, “Better the devil you know than a world you don't? Intolerance of uncertainty and worldview explanations for belief in conspiracy theories,” Personality and Individual Differences, vol. 98, pp. 345–354, 2016. View at Publisher · View at Google Scholar
  • Sylvain Druais, Agathe Doutriaux, Magali Cognet, Annabelle Godet, Christophe Lancon, Pierre Levy, Ludovic Samalin, and Pascal Guillon, “Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France,” Pharmacoeconomics, vol. 34, no. 4, pp. 363–391, 2016. View at Publisher · View at Google Scholar
  • Jiamei Lian, Xu-Feng Huang, Nagesh Pai, and Chao Deng, “Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications,” Pharmacological Research, vol. 106, pp. 51–63, 2016. View at Publisher · View at Google Scholar
  • 晓凤 贾, “Receptors and Related Drug Development for Schizophrenia: Research Advances,” Pharmacy Information, vol. 05, no. 02, pp. 19–24, 2016. View at Publisher · View at Google Scholar
  • Seung A Lee, Chai-Youn Kim, and Seung-Hwan Lee, “Non-Conscious Perception of Emotions in Psychiatric Disorders: The Unsolved Puzzle of Psychopathology,” Psychiatry Investigation, vol. 13, no. 2, pp. 165, 2016. View at Publisher · View at Google Scholar
  • Enrico Paolini, Patrizia Moretti, and Michael T. Compton, “Delusions in First-Episode Psychosis: Principal Component Analysis of Twelve Types of Delusions and Demographic and Clinical Correlates of Resulting Domains,” Psychiatry Research, 2016. View at Publisher · View at Google Scholar
  • R. L. Carhart-Harris, M. Kaelen, M. Bolstridge, T. M. Williams, L. T. Williams, R. Underwood, A. Feilding, and D. J. Nutt, “The paradoxical psychological effects of lysergic acid diethylamide (LSD),” Psychological Medicine, vol. 46, no. 7, pp. 1379–1390, 2016. View at Publisher · View at Google Scholar
  • Robert-Paul Juster, Catherine Raymond, Alexandra Bisson Desrochers, Olivier Bourdon, Nadia Durand, Nathalie Wan, Jens C. Pruessner, and Sonia J. Lupien, “Sex hormones adjust “sex-specific” reactive and diurnal cortisol profiles,” Psychoneuroendocrinology, vol. 63, pp. 282–290, 2016. View at Publisher · View at Google Scholar
  • Mark Shevlin, Eoin McElroy, Mogens Nygaard Christoffersen, Ask Elklit, Philip Hyland, and Jamie Murphy, “Social, familial and psychological risk factors for psychosis: A birth cohort study using the Danish Registry System,” Psychosis, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Miguel Bernardo, Fernando Cañas, Berta Herrera, and Marta García Dorado, “La adherencia predice la remisión sintomática y psicosocial en esquizofrenia: estudio naturalístico de la integración de los pacientes en la comunidad,” Revista de Psiquiatría y Salud Mental, 2016. View at Publisher · View at Google Scholar
  • June Ullevoldsæter Lystad, Erik Falkum, Vegard Øksendal Haaland, Helen Bull, Stig Evensen, Morris D. Bell, and Torill Ueland, “Neurocognition and occupational functioning in schizophrenia spectrum disorders: The MATRICS Consensus Cognitive Battery (MCCB) and workplace assessments,” Schizophrenia Research, vol. 170, no. 1, pp. 143–149, 2016. View at Publisher · View at Google Scholar
  • Beatrice Frajo-Apor, Silvia Pardeller, Georg Kemmler, Anna-Sophia Welte, and Alex Hofer, “Emotional Intelligence deficits in schizophrenia: The impact of non-social cognition,” Schizophrenia Research, vol. 172, no. 1-3, pp. 131–136, 2016. View at Publisher · View at Google Scholar
  • Kathryn E. Greenwood, Robin Morris, Vanessa Smith, Anna-Marie Jones, Douglas Pearman, and Til Wykes, “Virtual shopping: A viable alternative to direct assessment of real life function?,” Schizophrenia Research, 2016. View at Publisher · View at Google Scholar
  • Wing Chung Chang, Vivian Wing Yan Kwong, Gloria Hoi Kei Chan, Olivia Tsz Ting Jim, Emily Sin Kei Lau, Christy Lai Ming Hui, Sherry Kit Wa Chan, Edwin Ho Ming Lee, and Eric Yu Hai Chen, “Prediction of functional remission in first-episode psychosis: 12-month follow-up of the randomized-controlled trial on extended early intervention in,” Schizophrenia Research, vol. 173, no. 1-2, pp. 79–83, 2016. View at Publisher · View at Google Scholar
  • Leticia González-Blanco, Anne Marie D. Greenhalgh, Clemente Garcia-Rizo, Emilio Fernandez-Egea, Brian J. Miller, and Brian Kirkpatrick, “Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: A meta-analysis,” Schizophrenia Research, 2016. View at Publisher · View at Google Scholar
  • Kelsey A. Bonfils, Paul H. Lysaker, Kyle S. Minor, and Michelle P. Salyers, “Affective empathy in schizophrenia: a meta-analysis,” Schizophrenia Research, 2016. View at Publisher · View at Google Scholar
  • O.V. Vikhreva, V.I. Rakhmanova, D.D. Orlovskaya, and N.A. Uranova, “Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: A post-mortem morphometric study,” Schizophrenia Research, 2016. View at Publisher · View at Google Scholar
  • G. Baudin, O. Godin, M. Lajnef, B. Aouizerate, F. Berna, L. Brunel, D. Capdevielle, I. Chereau, J.M. Dorey, C. Dubertret, J. Dubreucq, C. Faget, G. Fond, F. Gabayet, H. Laouamri, C. Lancon, Y. Le Strat, A.M. Tronche, D. Misdrahi, R. Rey, C. Passerieux, A. Schandrin, M. Urbach, P. Vidalhet, P.M. Llorca, F. Schürhoff, F. Berna, O. Blanc, L. Brunel, E. Bulzacka, D. Capdevielle, I. Chereau-Boudet, G. Chesnoy-Servanin, J.M. Danion, T. D'Amato, A. Deloge, C. Delorme, H. Denizot, M. De Pradier, J.M. Dorey, C. Dubertret, J. Dubreucq, C. Faget, C. Fluttaz, G. Fond, S. Fonteneau, F. Gabayet, E. Giraud-Baro, M.C. Hardy-Bayle, D. Lacelle, C. Lançon, H. Laouamri, M. Leboyer, T. Le Gloahec, Y. Le Strat, P.M. Llorca, E. Metairie, D. Misdrahi, I. Offerlin-Meyer, C. Passerieux, P. Peri, S. Pires, C. Portalier, R. Rey, C. Roman, M. Sebilleau, A. Schandrin, F. Schurhoff, A. Tessier, A.M. Tronche, M. Urbach, F. Vaillant, A. Vehier, P. Vidailhet, J. Vilain, E. Vilà, H. Yazbek, and A. Zinetti-Bertschy, “Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia,” Schizophrenia Research, 2016. View at Publisher · View at Google Scholar
  • Thais Rabanea-Souza, Henrique T. Akiba, Arthur A. Berberian, Rodrigo A. Bressan, Álvaro M. Dias, and Acioly L.T. Lacerda, “Neuropsychological correlates of remission in chronic schizophrenia subjects: The role of general and task-specific executive processes,” Schizophrenia Research: Cognition, vol. 3, pp. 39–46, 2016. View at Publisher · View at Google Scholar
  • Forough Riahi, Maryam Izadi-mazidi, Ali Ghaffari, Elham Yousefi, and Shahram Khademvatan, “Comparison of Plasma Neurosteroid and Prolactin Levels in Patients with Schizophrenia and Healthy Individuals,” Scientifica, vol. 2016, pp. 1–6, 2016. View at Publisher · View at Google Scholar
  • S. M. Cotton, K. M. Filia, A. Ratheesh, K. Pennell, S. Goldstone, and P. D. McGorry, “Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health,” Social Psychiatry And Psychiatric Epidemiology, vol. 51, no. 1, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  • Youssef Kouidrat, Ali Amad, Nathalie Renard, Florianne Corneille, Jean-Daniel Lalau, and Gwenolé Loas, “Prise en charge des troubles du comportement alimentaire dans la schizophrénie,” Soins Psychiatrie, vol. 37, no. 304, pp. 39–43, 2016. View at Publisher · View at Google Scholar
  • Rao Fu, Xiao-Guang Luo, Yan Ren, Zhi-Yi He, and Hong Lv, “Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment,” Translational Neurodegeneration, vol. 5, no. 1, 2016. View at Publisher · View at Google Scholar
  • Martina Klein, Michaela Schmoeger, Siegfried Kasper, and Alexandra Schosser, “Meta-analysis of the COMT Val158Met polymorphism in major depressive disorder: the role of gender,” World Journal Of Biological Psychiatry, vol. 17, no. 2, pp. 147–158, 2016. View at Publisher · View at Google Scholar
  • Terrell Holloway, and Javier Gonzalez-Maeso, “Epigenetic Mechanisms of Serotonin Signaling,” Acs Chemical Neuroscience, vol. 6, no. 7, pp. 1099–1109, 2015. View at Publisher · View at Google Scholar
  • M. Möller, T. Swanepoel, and B. H. Harvey, “Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development,” ACS Chemical Neuroscience, pp. 150402134223006, 2015. View at Publisher · View at Google Scholar
  • Rosaria Di Lorenzo, Alessandra Amoretti, Samantha Baldini, Marcello Soli, Giulia Landi, Gabriella Pollutri, Rossella Corradini, and Paola Ferri, “Homocysteine levels in schizophrenia patients newly admitted to an acute psychiatric ward,” Acta Neuropsychiatrica, vol. 27, no. 6, pp. 336–344, 2015. View at Publisher · View at Google Scholar
  • A. L. Sutterland, G. Fond, A. Kuin, M. W. J. Koeter, R. Lutter, T. van Gool, R. Yolken, A. Szoke, M. Leboyer, and L. de Haan, “ Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis ,” Acta Psychiatrica Scandinavica, 2015. View at Publisher · View at Google Scholar
  • M. De Hert, J. Peuskens, T. Sabbe, A. J. Mitchell, B. Stubbs, P. Neven, H. Wildiers, and J. Detraux, “Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review,” Acta Psychiatrica Scandinavica, 2015. View at Publisher · View at Google Scholar
  • Menka Tsantefski, Alun C. Jackson, and Cathy Humphreys, “A delicate balance: intervention with mothers with dual diagnosis and their infants,” Advances in Dual Diagnosis, vol. 8, no. 2, pp. 78–89, 2015. View at Publisher · View at Google Scholar
  • Ian Hamilton, Paul Galdas, and Holly Essex, “Cannabis psychosis, gender matters,” Advances in Dual Diagnosis, vol. 8, no. 3, pp. 153–162, 2015. View at Publisher · View at Google Scholar
  • Sadao Otsuka, Mie Matsui, Takatoshi Hoshino, Kayoko Miura, Yuko Higuchi, and Michio Suzuki, “The Effectiveness and Applicability of Compensatory Cognitive Training for Japanese Patients with Schizophrenia: A Pilot Study,” Advances in Psychiatry, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Marcelo Valencia, Juan A. Moriana, Alex Kopelowicz, Steven R. Lopez, and Robert P. Liberman, “Social-Skills Training for Spanish-Speaking Persons with Schizophrenia: Experiences From Latin America, Spain, and the United States,” American Journal of Psychiatric Rehabilitation, vol. 18, no. 3, pp. 209–246, 2015. View at Publisher · View at Google Scholar
  • Marsal Sanches, Isabelle E. Bauer, Juan F. Galvez, Giovana B. Zunta-Soares, and Jair C. Soares, “The Management of Cognitive Impairment in Bipolar Disorder: Current Status and Perspectives,” American Journal Of Therapeutics, vol. 22, no. 6, pp. 477–486, 2015. View at Publisher · View at Google Scholar
  • Anne Gut-Fayand, “Éducation thérapeutique du patient et schizophrénies débutantes,” Annales Médico-psychologiques, revue psychiatrique, 2015. View at Publisher · View at Google Scholar
  • Federica Pinna, Luca Deriu, Enrica Diana, Valeria Perra, Rachele Pisu Randaccio, Lucia Sanna, Massimo Tusconi, and Bernardo Carpiniello, “Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders,” Annals of General Psychiatry, vol. 14, no. 1, 2015. View at Publisher · View at Google Scholar
  • Kiran Jakhar, Triptish Bhatia, Rahul Saha, and Smita Deshpande, “A Cross Sectional Study of Prevalence and Correlates of Current and Past Risks in Schizophrenia,” Asian Journal of Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Jayashri Kulkarni, and Kate Reeve-Parker, “Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey,” Australasian Psychiatry, vol. 23, no. 3, pp. 258–264, 2015. View at Publisher · View at Google Scholar
  • Antonio Vita, Luca De Peri, Giacomo Deste, Stefano Barlati, and Emilio Sacchetti, “The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies,” Biological Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Christina Daniel, and Oliver J. Mason, “Predicting Psychotic-Like Experiences during Sensory Deprivation,” BioMed Research International, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Christina Daniel, and Oliver J. Mason, “Predicting Psychotic-Like Experiences during Sensory Deprivation,” Biomed Research International, 2015. View at Publisher · View at Google Scholar
  • Chung-Chieh Hung, and Yung-Wen Ku, “Influencing and moderating factors analyzed in the group art therapy of two schizophrenic inpatients,” BioMedicine, vol. 5, no. 4, 2015. View at Publisher · View at Google Scholar